Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,184 | 98,896 | 101,732 | 119,437 | 101,705 |
| Marketable Securities | 320,217 | 363,725 | 375,833 | 371,066 | 187,850 |
| TOTAL | $463,137 | $474,878 | $482,683 | $495,622 | $294,318 |
| Non-Current Assets | |||||
| PPE Net | 20 | 34 | 399 | 462 | 404 |
| Other Non-Current Assets | 1,695 | 1,256 | 7,793 | 7,803 | 7,848 |
| TOTAL | $1,715 | $1,290 | $8,192 | $8,265 | $8,252 |
| Total Assets | $464,852 | $476,168 | $490,875 | $503,887 | $302,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,640 | 2,159 | 1,429 | 2,351 | 1,562 |
| Accrued Expenses | 9,847 | 14,409 | 13,221 | 12,860 | 12,410 |
| TOTAL | $11,487 | $16,568 | $14,650 | $15,211 | $13,972 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 103 | 204 | 302 |
| TOTAL | $N/A | $N/A | $103 | $204 | $302 |
| Total Liabilities | $11,487 | $16,568 | $14,753 | $15,415 | $14,274 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,905 | 59,800 | 59,347 | 59,236 | 49,069 |
| Common Shares | 61 | 59 | 59 | 59 | 49 |
| Retained earnings | -370,793 | -347,166 | -317,499 | -297,351 | -272,016 |
| Other shareholders' equity | -382 | 334 | 221 | -177 | -16 |
| TOTAL | $453,365 | $459,600 | $476,122 | $488,472 | $288,296 |
| Total Liabilities And Equity | $464,852 | $476,168 | $490,875 | $503,887 | $302,570 |